NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAAA E-041-2000-0-US-02 METHODS of And Compounds For Inhibiting Calpains US National Stage 09/847,872 6448245 Abandoned PDF
NIAAA E-041-2000-0-PCT-03 METHODS FOR INHIBITING CALPAIN PCT PCT PCT/US01/40652 Expired
NHLBI E-250-2001-0-PCT-02 Regulatory Nucleic Acid For The ABC1 Gene, Molecules Modifying Its Activity And Therapeutics Uses PCT PCT PCT/EP01/005488 Expired
NCI E-216-2001-0-US-01 Soybean Leachate: Plant Inhibitor And Potential Cancer therapeutic US 60/288,309 Abandoned
NICHD E-293-1998-0-US-03 Cloning and Characterization of Two M-RNA Transcription Factors US National Stage 09/830,942 Abandoned
NCI E-223-1998-0-US-03 p53 VEGF Regulate Tumor Growth of NOS2 Expressing Cancer Cells US National Stage 09/830,977 Abandoned
NINDS E-291-1999-0-PCT-02 DERIVATION OF MIDBRAIN DOPPAMINERGIC NEURONS FROM EMBRYONIC STEM CELLS PCT PCT PCT/US01/14051 Expired
NCI E-179-2001-0-US-01 Identification of a Cell Surface Receptor For Papillomaviruses US 60/287,776 Abandoned
NCI E-157-2000-0-AU-05 Immunogenicity Using a Combination of DNA And Vaccinia Virus Vector Vaccines AU National Stage 2001259291 Expired
NCI E-259-1998-2-US-06 Variants of Humanized Anti-Carcinoma MAB CC49 US National Stage 09/830,748 6818749 Expired PDF
NCI E-157-2000-0-PCT-02 Improved Immunogenicity Using a Combination of DNA And Vaccinia Virus Vector Vaccines PCT PCT PCT/US2001/013968 Expired
NCI E-157-2000-0-EP-04 Improved Immunogenicity Using a Combination of DNA And Vaccinia Virus Vector Vaccines EP National Stage 01932792.3 Abandoned
NCI E-157-2000-0-CA-06 Improved Immunogenicity Using a Combination of DNA And Vaccinia Virus Vector Vaccines CA National Stage 2407303 Abandoned
NCI E-157-2000-0-JP-07 Improved Immunogenicity Using a Combination of DNA And Vaccinia Virus Vector Vaccines JP National Stage 2001-579837 Abandoned
NIA E-175-2001-0-US-01 Method And Structures For Microengineering Neocartilage Scaffolds US 60/286,852 Abandoned
NICHD E-163-2000-0-US-02 Use of Cumulative Distribution Functions to Determine Protein Purity And Homogeneity. US ORD 09/844,962 Abandoned
NCI E-215-1994-0-US-08 METHOD OF PRODUCING SINGLE-CHAIN FV MOLECULES US CON 09/844,650 Abandoned
NHLBI E-301-2000-0-US-01 Protein From Group B Streptococcus Responsible For Pulmonary Hypertension in Neonates, And Methods of Use Thereof US 60/287,235 Abandoned
NINDS E-206-2000-1-US-01 Mehtods of Increasing Distribution of Nucleic Acids US 60/286,308 Abandoned
NCI E-285-2003-0-US-01 A Method For Integrating Laser Capture Microdissection With Layered Expression Scanning US 60/286,258 Abandoned
NCI E-302-2000-1-US-01 Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway As Selective Therapeutic Strategy Against Melanomas US 60/285,690 Abandoned
NCI E-187-2001-0-US-03 Structure Determination of Material Using Electron Microscopy US National Stage 10/475,821 6987266 Abandoned PDF
NCI E-187-2001-0-US-01 Structure Determination of Material Using Electron Microscopy US 60/285,819 Abandoned
NIAID E-096-2000-0-PCT-02 INDUCIBLE PLASMID VECTOR ENCODING TGF-beta AND USES THEREOF PCT PCT PCT/US01/12980 Abandoned
NCI E-087-1996-0-US-05 HETEROLOGOUS BOOSTING IMMUNIZATIONS US CON 09/838,987 Abandoned
NCI E-190-1998-0-US-07 Water-Soluble Drugs and Methods for Their Production US National Stage 09/743,873 6747055 Abandoned PDF
NCI E-149-1993-1-AU-03 PARTIAL INTRON SEQUENCE OF VON HIPPEL-LINDAU (VHL) DISEASE GENE AND ITS USE IN DIAGNOSIS OF DISEASE AU DIV 37085/01 Abandoned
NIMH E-203-2001-0-US-01 Use of Protein Denaturing Agents, or Chaotropic Agents as Potential Aids in The Treatment of Prion Associated Diseases US ORD 09/835,537 7521479 Expired PDF
NCI E-217-1998-0-US-07 Virus-Like Particles for the Induction of Autoantibodies US CON 09/835,124 6719978 Expired PDF
NICHD E-225-1997-4-US-01 Methods For The Production of Purified Recombinant Human Treatment of Impaired Lung function & To Enhance Lyphocyte Production US CIP 09/835,784 Abandoned
NICHD E-225-1997-3-US-01 Methods And Compositions For The Treatment of Fribrotic Conditions & Impaired Lung Function & to Enchance Lyphocyte Production US CIP 09/549,926 Abandoned
NCI E-301-1998-2-US-06 Combination Therapy With VIP Antagonist US National Stage 09/807,557 6630124 Abandoned PDF
NCI E-157-1994-1-AU-04 METHODS AND COMPOSITIONS FOR DETECTING DIHYROPYRIMIDINE DEHYDROGENASE SPLICING MUTATIONS AU DIV 35154/01 Expired
NIMH E-098-2001-0-US-01 Modified Random Primers For Hybridization Detection US 60/283,423 Abandoned
NINDS E-238-1992-1-US-10 ST-B17 SEROTONIN RECEPTOR US CON 09/829,631 6844190 Abandoned PDF
NCI E-253-1993-0-US-09 Self-Assmbling Recombinant Papillomavirus Capsid Protein US CON 09/832,065 Abandoned
NCI E-053-2001-0-US-01 PRAC and PRAC-Y, Smalll Nuclear Proteins Found in Prostate and Colon Cancer, and Uses Thereof US 60/282,704 Abandoned
NIAMS E-067-2001-0-US-01 Synthesis and Secretion of Native Recombinant Lysomal Enzymes By Liver US 60/282,422 Abandoned
NCI E-279-1999-0-CA-06 AMINOFLAVONE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF CA National Stage 2405747 Abandoned
NCI E-279-1999-0-AU-05 AMINOFLAVONE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE AU National Stage 2001249940 Abandoned
NCI E-279-1999-0-DE-08 AMINOFLAVONE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF DE EP 01923228.9 Abandoned
NCI E-279-1999-0-FR-09 AMINOFLAVONE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE FR EP 01923228.9 Abandoned
NCI E-279-1999-0-BE-15 AMINOFLAVONE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE BE EP 01923228.9 Abandoned
NCI E-279-1999-0-ES-13 AMINOFLAVONE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE ES EP 01923228.9 Abandoned
NCI E-279-1999-0-CH-10 AMINOFLAVONE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE CH EP 01923228.9 Abandoned
NCI E-279-1999-0-IE-11 AMINOFLAVONE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE IE EP 01923228.9 Abandoned
NCI E-279-1999-0-IT-12 AMINOFLAVONE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE IT EP 01923228.9 Abandoned
NCI E-279-1999-0-LU-14 AMINOFLAVONE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF LU EP 01923228.9 Abandoned
NCI E-279-1999-0-GB-07 AMINOFLAVONE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF GB EP 01923228.9 Abandoned
NCI E-279-1999-0-EP-04 AMINOFLAVONE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE EP National Stage 01923228.9 Abandoned